Market Cap | ₹118Cr |
ROE | 1.26% |
P/E Ratio(TTM) | 274.50 |
EPS(TTM) | 0.04 |
P/B Ratio | 1.95 |
Dividend Yield | 0.00% |
Industry P/E | 40.33 |
Book Value | 5.62 |
Debt to Equity | 0.19 |
Face Value | 2 |
Parent Organisation | Vaishali Pharma Limited |
Managing Director | Mr. Atul Vasani |
NSE Symbol | VAISHALI |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.92 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.00 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.72 | ||
Wockhardt | NA (0.00%) | -151.40 |